BackTable / Urology / Podcast / Episode #263
Renal Cancer Management: Tumor Board Discussion & Treatments
with Dr. Raquib Hannan, Dr. Brandon Manley and Dr. Rana McKay
Kidney cancer management is evolving. How are experts adapting? In this installment of BackTable Tumor Board, Dr. Brandon Manley (Urologic Oncology, Moffitt Cancer Center), Dr. Raquibul Hannan (Radiation Oncology, UT Southwestern), and Dr. Rana McKay (Medical Oncology, UC San Diego) join guest host Mark Ball (Urologic Oncology, National Cancer Institute) to share their multidisciplinary perspectives on challenging, real-world kidney cancer cases.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

BackTable, LLC (Producer). (2025, October 7). Ep. 263 – Renal Cancer Management: Tumor Board Discussion & Treatments [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Raquibul Hannan
Dr. Raquibul Hannan is the chief of the genitourinary radiation oncology service at UT Southwestern in Dallas, Texas.
Dr. Brandon Manley
Dr. Brandon Manley is a urologic oncologist at Moffitt Cancer Center in Tampa, Florida.
Dr. Mark Ball
Dr. Mark Ball is an attending surgeon at the Urologic Oncology Branch of the National Cancer Institute and Associate Program Director of the Urologic Oncology Fellowship Program in Bethesda, Maryland.
Dr. Rana McKay
Dr. Rana McKay is a medical oncologist and associate professor at UC San Diego Health in California.
Synopsis
The conversation covers diagnostic dilemmas, navigating the treatment options of surgery, systemic therapy, and radiation, and the importance of a multidisciplinary approach. Through detailed case reviews, the panel highlights practical pearls, emerging clinical trials, and collaborative approaches that exemplify modern kidney cancer care.
Timestamps
0:00 - Introduction
02:20 - Case 1 (Incidental Renal Mass)
16:52 - Case 2 (Bilateral Renal Masses)
37:22 - Case 3 (Locally Advanced Renal Mass)
56:34 - Case 4 (Symptomatic, Metastatic Disease)
01:14:00 - Final Takeaways
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.